Letter to Andrew Slavitt, Acting Administrator, Centers for Medicare and Medicaid Servicess - Support for Proposed Biosimilar Drug Payment Rule from CMS

Letter

Date: Sept. 28, 2015
Location: Washington, DC

Only available in PDF format; please see source to view document.


Source
arrow_upward